Here, we explored the expression profiles of 17 S100 genes in glioma and found that twelve genes (S100A1-6, S100A8-11, S100A13, S100A16, and S100Z) were aberrantly expressed in GBM relative to LGG both in the CGGA and TCGA datasets. This evidence concerns the gene S100Z and central nervous system cancer.